Assessment of Compliance of Glucosamine and Chondroitin Sulfate in Patients with Early Osteoarthritis of Knee
Parikshat Gopal, Nikhil Sood, Rupesh Prasad
Keywords :
Compliance, Early osteoarthritis of knee, Glucosamine and chondroitin sulfate
Citation Information :
Gopal P, Sood N, Prasad R. Assessment of Compliance of Glucosamine and Chondroitin Sulfate in Patients with Early Osteoarthritis of Knee. Journal of Medical Academics 2023; 6 (2):53-57.
Background: Osteoarthritis (OA) is one of the leading causes of knee disability. Depending upon the disease's stages, various management modalities are available with varying grades of success. However, being degenerative and gradually progressive disease compliance to the treatment has a significant role in the outcome.
Materials and methods: This prospective observational study was carried out at a tertiary care orthopedic center to assess the level of compliance to tablet glucosamine and chondroitin sulfate tablets in subjects with early OA. Around 50 consecutive issues visiting the outpatient Department (OPD) of Orthopedics at Base Hospital, Delhi were included in the study after clinical and radiological confirmation of the diagnosis. Patients were advised to tablet glucosamine and chondroitin sulfate and followed up for 12 weeks. The Morisky Scale Questionnaire assessed compliance with the prescribed medication.
Results: This study confirms poor compliance with the prescribed medication among geriatric subjects with early OA. Various other factors, such as literacy level, family status, functional status, associated medical illnesses, daily medicinal load, and awareness about the disease, significantly impact the patient's compliance.
Silverstein FE, Graham DY, Senior JR, et al. Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving NSAIDS. Ann Intern Med 1995;123(4):241–249. DOI: 10.7326/0003-4819-123-4-199508150-00001
Hochberg MC, Roy DA, Kenneth DB, et al. Guidelines for the medical management of osteoarthritis. Part II. Osteoarthritis of the knee. American College of Rheumatology. Arthritis Rheum 1995;38(11):1541–1546. DOI: 10.1002/art.1780381104
Smalley WE, Ray WA, Daugherty JR, et al. Nonsteroidal anti-inflammatory drugs and the incidence of hospitalizations for peptic ulcer disease in elderly persons. Am J Epidemiol 1995;141(6):539–545. DOI: 10.1093/oxfordjournals.aje.a117469
Setnikar I, Giacchetti C, Zanolo G. Pharmacokinetics of glucosamine in the dog and in man. Arzneimittelforschung 1998;36(4):729–735. PMID: 3718596.
Ronca F, Palmieri L, Panicucci P, et al. Anti-inflammatory activity of chondroitin sulfate. Osteoarthritis Cartilage 1998;6(suppl A):14–21. DOI: 10.1016/s1063-4584(98)80006-x
McAlindon TE, LaValley MP, Gulin JP, et al. Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis. JAMA 2000;283(11):1469–1475. DOI: 10.1001/jama.283.11.1469
Tsai K, Chen J, Wen C, et al. Medication adherence among geriatric outpatients prescribed multiple medications. Am J Geriatr Pharmacother 2012;10(1):61–68. DOI: 10.1016/j.amjopharm.2011.11.005
Osterberg L, Blaschke T. Adherence to medication. N Eng J Med 2005;353(5):487–497. DOI: 10.1056/NEJMra050100
Jin J, Sklar G, Oh V, et al. Factors affecting therapeutic compliance: a review from the patient's perspective. Therapeut Clin Risk Manag 2008;4(1):269–286. DOI: 10.2147/tcrm.s1458
Altman R, Asch E, Bloch D, et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 1986;29(8):1039–1049. DOI: 10.1002/art.1780290816
Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986;24(1):67–74. DOI: 10.1097/00005650-198601000-00007
Kon E, Filardo G, Drobnic M, et al. Non-surgical management of early knee osteoarthritis. Knee Surg Sports Traumatol Arthrosc 2012;20(3):436–449. DOI: 10.1007/s00167-011-1713-8
Pinals RS. Pharmacologic treatment of osteoarthritis. Clin Ther 1992;14(3):336–346.
Blenkiron P. The elderly and medication: understanding and compliance in a family practice. Postgrad Med J 1996;72(853):671–676. DOI: 10.1136/pgmj.72.853.671
Tiv M, Viel JF, Mauny F, et al. Medication adherence in type 2 diabetes: the ENTRED study 2007, a French population based study. PLoS One 2012;7(3):e32412. DOI: 10.1371/journal.pone.0032412
Benner JS, Glynn RJ, Mogun H, et al. Long-term persistence in use of statin therapy in elderly patients. JAMA 2002;288(4):455–461. DOI: 10.1001/jama.288.4.455
Okuno J, Yanagi H, Tomura S, et al. Compliance and medication knowledge among elderly Japanese home-care recipients. Eur J Clin Pharmacol 1999;55(2):145–149. DOI: 10.1007/s002280050609
Nichols G, Poirier S. Optimizing adherence to pharmaceutical care plans. J Am Pharmaceut Assoc 2000;40(4):475–485. PMID: 10932456.
Ho PM, Bryson C, Rumsfeld JS. Medication adherence: its importance in cardiovascular outcomes. Circulation 2009;119(23):3028–3035. DOI: 10.1161/CIRCULATIONAHA.108.768986
Shams MEE, Barakat EAM. Measuring the rate of therapeutic adherence among outpatients with T2DM in Egypt. Saudi Pharm J 2010;18(4):225–232. DOI: 10.1016/j.jsps.2010.07.004
Maclaughlin EJ, Raehl CL, Treadway AK, et al. Assessing medication adherence in the elderly: which tools to use in clinical practice? Drugs Aging 2005;22(3):231–255. DOI: 10.2165/00002512-200522030-00005
Ibrahim OH, Jirjees FJ, Mahdi HJ. Barriers affecting compliance of patients with chronic diseases: a preliminary study in United Arab Emirates (UAE) population. Asian J Pharmaceut Clin Res 2011;4(Suppl 2):42–45.